title: Risk perception after genetic counseling in patients with increased risk of cancer.
abstract: BACKGROUND
  Counselees are more aware of genetics and seek information, reassurance, screening and genetic testing. Risk counseling is a key component of genetic counseling process helping patients to achieve a realistic view for their own personal risk and therefore adapt to the medical, psychological and familial implications of disease and to encourage the patient to make informed choices 12.The aim of this study was to conceptualize risk perception and anxiety about cancer in individuals attending to genetic counseling.
  
  
  METHODS
  The questionnaire study measured risk perception and anxiety about cancer at three time points: before and one week after initial genetic counseling and one year after completed genetic investigations. Eligibility criteria were designed to include only index patients without a previous genetic consultation in the family. A total of 215 individuals were included. Data was collected during three years period.
  
  
  RESULTS
  Before genetic counseling all of the unaffected participants subjectively estimated their risk as higher than their objective risk. Participants with a similar risk as the population overestimated their risk most. All risk groups estimated the risk for children's/siblings to be lower than their own. The benefits of preventive surveillance program were well understood among unaffected participants.The difference in subjective risk perception before and directly after genetic counseling was statistically significantly lower in all risk groups. Difference in risk perception for children as well as for population was also statistically significant. Experienced anxiety about developing cancer in the unaffected subjects was lower after genetic counseling compared to baseline in all groups. Anxiety about cancer had clear correlation to perceived risk of cancer before and one year after genetic investigations.The affected participants overestimated their children's risk as well as risk for anyone in population. Difference in risk perception for children/siblings as for the general population was significant between the first and second measurement time points. Anxiety about developing cancer again among affected participants continued to be high throughout this investigation.
  
  
  CONCLUSIONS
  The participant's accuracy in risk perception was poor, especially in low risk individuals before genetic counseling. There was a general trend towards more accurate estimation in all risk groups after genetic counseling. The importance of preventive programs was well understood. Cancer anxiety was prevalent and associated with risk perception, but decreased after genetic counseling.1 National Society of Genetic Counselors (2005), Genetic Counseling as a Profession. Available at http://www.nsgc.org/about/definition.cfm (accessed November 25th 2007)2 Julian-Reynier C., Welkenhuysen M-, Hagoel L., Decruyenaere M., Hopwood P. (2003) Risk communication strategies: state of the art and effectiveness in the context of cancer genetic services. Eur J of Human Genetics 11, 725736.
authors.affiliation: Department of Clinical Genetics, Karolinska University Hospital, L5:03, S-17176 Stockholm, Sweden. johanna.rantala@ki.se
authors.forename: Johanna
authors.initials: J
authors.lastname: Rantala
authors.forename: Ulla
authors.initials: U
authors.lastname: Platten
authors.forename: Gunilla
authors.initials: G
authors.lastname: Lindgren
authors.forename: Bo
authors.initials: B
authors.lastname: Nilsson
authors.forename: Brita
authors.initials: B
authors.lastname: Arver
authors.forename: Annika
authors.initials: A
authors.lastname: Lindblom
authors.forename: Yvonne
authors.initials: Y
authors.lastname: Brandberg
references.citation: Br J Cancer. 1993 Mar;67(3):612-4
references.pmid: 8439512
references.citation: Psychooncology. 1998 Sep-Oct;7(5):402-12
references.pmid: 9809331
references.citation: Fam Cancer. 2001;1(1):31-7
references.pmid: 14574013
references.citation: J Clin Oncol. 2004 May 1;22(9):1736-42
references.pmid: 15117997
references.citation: J Med Genet. 2002 Jul;39(7):526-30
references.pmid: 12114489
references.citation: Eur J Hum Genet. 2003 Oct;11(10):725-36
references.pmid: 14512961
references.citation: Fam Cancer. 2003;2(3-4):159-68
references.pmid: 14707527
references.citation: J Genet Couns. 2005 Feb;14(1):55-69
references.pmid: 15789156
references.citation: J Natl Cancer Inst. 2000 Aug 16;92(16):1345-51
references.pmid: 10944557
references.citation: Br J Cancer. 1994 Nov;70(5):934-8
references.pmid: 7947100
references.citation: J Clin Epidemiol. 2002 Jul;55(7):665-75
references.pmid: 12160914
references.citation: J Natl Cancer Inst Monogr. 1999;(25):44-51
references.pmid: 10854457
references.citation: World J Surg. 1997 Feb;21(2):205-9
references.pmid: 8995080
references.citation: Health Psychol. 1996 Nov;15(6):423-9
references.pmid: 8973921
references.citation: Br J Surg. 1990 Dec;77(12):1367-70
references.pmid: 2276021
references.citation: J Natl Cancer Inst Monogr. 1999;(25):59-66
references.pmid: 10854459
references.citation: Community Genet. 2003;6(4):214-23
references.pmid: 15331867
references.citation: Genet Couns. 2000;11(2):127-46
references.pmid: 10893664
references.citation: Am J Gastroenterol. 2001 Oct;96(10):2992-3003
references.pmid: 11693338
references.citation: Eur J Cancer. 2004 Feb;40(3):365-74
references.pmid: 14746854
references.citation: Fam Cancer. 2006;5(1):61-75
references.pmid: 16528610
references.citation: J Clin Oncol. 2000 Jun;18(11):2250-7
references.pmid: 10829045
references.citation: Gastroenterology. 1995 Sep;109(3):1015-7
references.pmid: 7657089
references.citation: Community Genet. 1998;1(2):78-83
references.pmid: 11657631
references.citation: Br J Cancer. 2002 Jan 7;86(1):43-50
references.pmid: 11857010
references.citation: Cancer Detect Prev. 2007;31(6):457-64
references.pmid: 18061369
references.citation: Br J Cancer. 1998;77(1):174-9
references.pmid: 9459165
references.citation: Ann Intern Med. 1993 May 15;118(10):785-90
references.pmid: 8470852
references.citation: J Genet Couns. 2007 Apr;16(2):211-22
references.pmid: 17279329
references.citation: Genet Test. 2005 Spring;9(1):54-65
references.pmid: 15857188
references.citation: Fam Cancer. 2005;4(2):151-61
references.pmid: 15951967
references.citation: Eur J Cancer. 2004 Sep;40(14):2056-63
references.pmid: 15341979
references.citation: J Genet Couns. 2005 Apr;14(2):119-32
references.pmid: 15959643
references.citation: J Clin Oncol. 1998 May;16(5):1650-4
references.pmid: 9586874
references.citation: Br J Surg. 1976 Jan;63(1):13-18
references.pmid: 1267868
references.citation: N Engl J Med. 1994 Dec 22;331(25):1669-74
references.pmid: 7969357
references.citation: J Med Genet. 2002 Sep;39(9):689-94
references.pmid: 12205115
references.citation: Eur J Hum Genet. 2008 Apr;16(4):445-52
references.pmid: 18197196